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BACKGROUND: Most cases of congenital heart disease (CHD) are 
sporadic and nonsyndromic, with poorly understood etiology. Rare genetic 
variants have been found to affect the risk of sporadic, nonsyndromic 
CHD, but individual studies to date are of only moderate sizes, and none 
to date has incorporated the ohnolog status of candidate genes in the 
analysis. Ohnologs are genes retained from ancestral whole-genome 
duplications during evolution; multiple lines of evidence suggest ohnologs 
are overrepresented among dosage-sensitive genes. We integrated large-
scale data on rare variants with evolutionary information on ohnolog 
status to identify novel genetic loci predisposing to CHD.
METHODS: We compared copy number variants present in 4634 
nonsyndromic CHD cases derived from publicly available data resources 
and the literature, and >27 000 healthy individuals. We analyzed deletions 
and duplications independently and identified copy number variant 
regions exclusive to cases. These data were integrated with whole-exome 
sequencing data from 829 sporadic, nonsyndromic patients with Tetralogy 
of Fallot. We placed our findings in an evolutionary context by comparing 
the proportion of vertebrate ohnologs in CHD cases and controls.
RESULTS: Novel genetic loci in CHD cases were significantly enriched 
for ohnologs compared with the genome (χ2 test, P<0.0001, OR =1.253 
[95% CI, 1.199–1.309]). We identified 54 novel candidate protein-coding 
genes supported by both: (1) copy number variant and whole-exome 
sequencing data; and (2) ohnolog status.
CONCLUSIONS: We have identified new CHD candidate loci, and show 
for the first time that ohnologs are overrepresented among CHD genes. 
Incorporation of evolutionary metrics may be useful in refining candidate 
genes emerging from large-scale genetic evaluations of CHD.
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Congenital heart disease (CHD) is the most prevalent birth defect in humans, occurring in ≈8 per 1000 live births, and consisting of malformation of the 
heart and the great vessels.1 Around 20% of all CHDs can 
be attributed to chromosomal imbalances such as Down 
and Turner, and 22q11 deletion syndromes; around 80% 
occur as sporadic, nonsyndromic CHD. In such cases, CHD 
behaves overall as a genetically complex trait with moder-
ate heritability. Previous genome-wide investigations into 
CHD have found evidence for rare causative copy number 
variants (CNVs) and single nucleotide variants (SNVs), and 
associations with common SNVs in GWAS.2–6 It has been 
estimated in previous studies that several hundred genes 
may be involved in polygenic CHD susceptibility; there-
fore, many remain to be discovered.7
CNVs are 1 kilobase (kb) to several megabase (Mb) 
sized regions of duplication and deletion in the genome. A 
2014 meta-analysis of CNVs in 1694 nonsyndromic CHD 
cases identified 79 chromosomal regions in which 5 or 
more CHD cases had overlapping imbalances.5 The esti-
mated prevalence of pathogenic CNVs in nonsyndromic 
CHD patients is 4% to 14%, whereas in syndromic CHD 
patients it is 15% to 20% (the most common being 22q11 
deletion syndrome).3,8,9 There are multiple mechanisms by 
which a CNV may lead to disease including the disruption 
of chromosome structure, alteration of gene expression 
due to disruption of regulatory elements, and changes of 
the relative amounts of dosage-sensitive genes.10
The dosage-balance model postulates that, for 
genes that are in stoichiometric relationships (eg, 
forming protein complexes with other genes), any 
perturbation in their relative ratios will tend to be del-
eterious.10 In the early course of vertebrate evolution, 
around 500 million years ago, 2 whole-genome dupli-
cations, during which gene stoichiometry throughout 
the genome was preserved, as all genes were duplicat-
ed, took place. Periods of gene loss followed each of 
these events, resulting in the retention of some whole-
genome duplication paralogs in the genome (termed 
ohnologs) and the loss of others. The dosage-balance 
model would predict that ohnologs should be enriched 
for dosage-sensitive genes.11 Ohnologs, of which there 
are around 7000 in the human genome, have indeed 
been shown to exhibit characteristics consistent with 
dosage-sensitivity: for example, ohnologs are enriched 
for haploinsufficient genes11,12; and Makino et al13 
reported, based on CNV data in healthy individuals 
from the Database of Genomic Variants, that genomic 
regions (≈2 Mb in size) near ohnologs are CNV deserts, 
indicating that those regions are dosage-balanced.
The formation and fixation of gene duplications 
within the genome are subject to different evolution-
ary mechanisms–small scale duplications (SSD) involving 
relatively few genes, and whole-genome duplication. A 
strong relationship between the evolutionary mechanism 
of duplication and phenotypic consequences, including 
heritable diseases, has been previously shown.14–16 Ohno-
logs have a significant association with certain human 
genetic diseases; for example 12 out of 16 reported can-
didate genes within the Down syndrome critical region 
(21q22.12, 21q22.13, and 21q22.2) are dosage-bal-
anced ohnologs.11 By contrast, genes arising from SSDs 
lack enrichment for disease association.17 In addition, 
ohnologs are enriched for genes involved in signaling and 
gene regulation, key cardiovascular developmental pro-
cesses.11 These considerations led us to hypothesize that 
ohnologs may be enriched among CHD causative genes.
We tested this hypothesis in a meta-analysis of 
CNV data including 4634 nonsyndromic CHD cases, 
and integrated these data with a WES (whole-exome 
sequencing) study of 829 cases of Tetralogy of Fallot 
(TOF), the commonest cyanotic CHD phenotype, which 
has been previously shown to have a significant etio-
logical contribution from CNVs.6 These were compared 
with control data, which were derived from large-scale 
genomic resources.18–21
METHODS
The appropriate institutional review bodies approved all 
recruitment of human participants in this study. The study 
corresponded with the stipulations of the Declaration of 
Helsinki, and all participants (or their parents, if affected 
probands were children too young to themselves consent) 
provided informed consent. Data from consortia were 
accessed subject to the applicable data-sharing agree-
ments. Summary data, analytic methods, and summary 
study materials will be made available to other research-
ers for purposes of reproducing the results or replicating 
the analyses reported here, on request to the correspond-
ing authors. Full Materials and Methods are available in the 
Data Supplement of the article.
RESULTS
Update of CHD CNV Data Set and 
Generation of Control CNV Data Set
We updated the previous meta-analysis of CNVs in 
nonsyndromic CHD cases,5 in a further 2882 nonsyn-
dromic CHD cases from DECIPHER (Database of Chro-
mosomal Imbalance and Phenotype in Humans using 
Ensembl Resources), ECARUCA (European Cytogeneti-
cists Association Register of Unbalanced Chromosome 
Abberations), ISCA (International Standards for Cytoge-
nomic Arrays) databases and further published stud-
ies investigating the role of CNVs in CHD.4,20,22–32 The 
updated CHD case CNV data set consists of 4634 unre-
lated individuals of different ancestries (Table  1). The 
outline workflow to identify candidate genes is shown 
in Figure 1. Filtering of the CHD case population against 
DECIPHER known microdeletion/microduplication syn-
dromes resulted in 224 cases being removed; this left 
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4410 CHD cases with 3362 deletion CNVs and 2540 
duplication CNVs which were used for further analysis 
(Figure I in the Data Supplement).
A control CNV data set was generated by acquiring 
CNV data from individuals not explicitly identified as 
having a developmental disorder, who were enrolled in 
the 1000 Genome Project Phase 3, Database of Genom-
ic Variants, DECIPHER, and published studies.21,27,28,33,34 
The control CNV data set resulted in 256 511 deletion 
CNVs, 84 343 duplication CNVs, and 6403 BOTH CNVs, 
that is, either deletion or duplication. gnomAD CNVs35 
were incorporated into the analysis as they became 
available and resulted in an additional 51 420 duplica-
tion CNVs and 198 611 deletion CNVs.
Comparison of CHD CNV Regions With 
Control CNV Regions
All CHD deletion and duplication CNV regions (coordi-
nates hg19) were compared against control deletion and 
duplication CNV regions, respectively. Any CHD CNV 
regions overlapping control CNV regions were exclud-
ed. As a result, we identified deletion and duplication 
CNV regions only seen in nonsyndromic CHD cases. The 
genes located in those regions were annotated using the 
Ensembl database. There were a number of genes that 
already had an assigned phenotype (Online Mendelian 
Inheritance in Man)36; among these, 59 had been previ-
ously associated with CHD pathogenesis such as ZIC3, 
NKX2-6, GATA4, JAG1, GJA1, and TBX5. All genes with 
Online Mendelian Inheritance in Man assigned pheno-
types were excluded from further analysis.
Novel genes found in the CNV regions only seen in 
CHD cases were then compared with an in-house list 
of 12 771 genes with novel or rare SNVs (either absent 
from ExAC or with frequency of <0.01) from WES data 
in 829 TOF cases.6 Genes supported by both CNV and 
WES data were included for further analysis. In total, 
3082 genes in deletion CNVs, 4297 genes in duplica-
tion CNVs, and 3068 in BOTH CNVs (ie, genes found 
in deletion and duplication CNVs) were also found in 
the TOF WES data with either high (nonsense variants, 
frameshift, splice variants) or medium (missense, splice 
variants) impact SNVs. This intersection of CNV and 
WES data led to an overall reduction of ≈60% in the 
number of candidate genes for CHD (Figure 2).
Ohnologs are Highly Enriched in CHD 
Cases Whereas SSD and Singleton Genes 
are Not
Ohnologs (N=7023) were identified using data from 
Singh et al,37 available at http://ohnologs.curie.fr/. SSDs 
(N=7014) were extracted from Ensembl gene trees.12 Any 
Table 1. Number of Cases in Previous and Current Meta-Analysis 
Studies as Well as Controls Used in the Current Study
Databases for CHD 
Cases
Thorsson et 
al5 Study
Current 
Study
Databases 
for Controls
Current 
Study
DECIPHER 279 1252 1000 
Genome 
phase 3
2504
ISCA 331 1107 DGV >6430
Published literature 814 1900 gnomAD 10738
CHDwiki 328 328 Published 
literature
356
ECARUCA 0 47 WTCC2 ≈6000
WES TOF (Page et al6) N/A 829 DDD 845
CHD indicates congenital heart disease; DDD, Deciphering Developmental 
Disorders study; 
DECIPHER, Database of Chromosomal Imbalance and Phenotype in 
Humans using Ensembl Resources; DGV, Database of Genomic Variants; 
ECARUCA, European Cytogeneticists Association Register of Unbalanced 
Chromosome Aberrations; ISCA, International Standards for Cytogenomic 
Arrays; WES TOF, whole-exome sequencing of Tetralogy of Fallot; and 
WTCC2, Wellcome Trust Case Control Consortium 2.
Figure 1. Overall methodology.  
Flowchart showing the methodology used to identify novel genetic loci for 
nonsyndromic congenital heart disease (CHD) cases. Potential pathogenic vari-
ants were novel or rare single nucleotide variants (either absent from ExAC or 
with frequency of <0.01). Candidate genes identified at the end of the work-
flow were subsequently analyzed for ohnolog status. BOTH indicates deleted/
duplicated; CNV, copy number variant; DEL, deletion; DUP, duplication; TOF, 
Tetralogy of Fallot; and WES, whole-exome sequencing.
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remaining genes that were neither found in the ohnolog 
data set nor identified as having a direct paralog were 
considered for the purpose of this study to be single-
tons. The frequencies of ohnologs, SSDs, and singletons 
among the candidate CHD genes were compared with 
their frequency in the human genome. Novel genes sup-
ported by the CNV data in CHD cases were found to 
be enriched for ohnologs (14.65% versus 12.05%, χ2 
test, P<0.0001; OR=1.253 [95% CI, 1.199–1.309]; Fig-
ure 3A). There were no differences in SSDs (Figure 3B) 
and an under-representation for singletons (Figure 3C) 
compared with the human genome. There was a 2.3-
fold increased enrichment of ohnologs in the genes 
supported by both CNV and WES data in CHD cases 
(χ2 test, P<0.0001, OR=3.751 [95% CI, 3.574–3.937]). 
In this instance, SSDs were also enriched in CHD cases 
compared with the human genome (χ2 test, P<0.0001; 
OR=1.437 [95% CI, 1.356–1.905]). However, ohno-
logs were 2-times elevated compared with SSD genes 
(33.94% versus 16.43%). Additionally, we assessed our 
methodology by applying it to a group of genes with 
strong a priori evidence for pathogenicity. The crowd-
sourced Genomics England PanelApp gene list for 
CHD (available at https://panelapp.genomicsengland.
co.uk/panels/212/), which represents a consensus view 
of causative genes, was highly enriched for ohnologs 
(76.6% versus 12.05%, χ2 test, P<0.0001; OR=23.89 
[95% CI, 12.33–46.18]). We, therefore, used ohnolog 
status as an additional candidate gene filter.
Candidate Genes Supported by Both CNV 
and WES Data of CHD Cases
To further refine our candidate genes, we integrated 
additional genomic resources including the top 5% 
ExAC CNV intolerance scores, probability of haploinsuf-
fieciency (pHI),38 probability of loss-of-function intoler-
ance (pLI),19 and RNAseq expression data from mouse 
embryonic hearts.39 Lastly, we incorporated ohnolog 
status. Genes from BOTH CNVs were analyzed twice; 
once with the metrics used for genes from deletion 
CNVs and once with the metrics used for genes from 
duplication CNVs (Figure 4).
This led to the identification of 9 candidate genes 
from deletion and BOTH CNVs: BRWD1, DIP2C, EYA3, 
GRB10, HNRNPC, RC3H2, SLIT3, TLN1, and UBASH3B. 
All 9 have the following properties: (1) loss-of-function 
(LoF) variants in the WES data, (2) found in deletion or 
BOTH CNV regions only seen in nonsyndromic CHD cas-
es, (3) top 5% of ExAC deletion CNV intolerance scores, 
(4) haploinsufficient (pHI ≥0.65) and unable to tolerate 
loss-of-function variants (pLI ≥0.9), (5) in the top 25% 
of highly expressed genes in mouse heart at E9.5 and 
E14.5, (6) ohnolog, (7) not present in the list of genes 
curated from the DDD study (Deciphering Developmen-
tal Disorders), and (8) not classified as human nonessen-
tial genes from the Sudmant study21 (Table 2).
In addition, we found 45 candidate genes from 
duplication and BOTH CNVs, which had the following 
properties: (1) high or medium impact SNVs in the WES 
data, (2) found in duplication and BOTH CNV regions 
only seen in nonsyndromic CHD cases, (3) top 5% of 
ExAC duplication CNV intolerance scores, (4) in the top 
25% of highly expressed genes in mouse heart at E9.5 
and E14.5, (5) ohnolog, (6) not present in the list of 
genes curated from the DDD study, and (7) not in the 
list of nonessential human genes from the Sudmant 
study21 (Table 2).
Pathway Enrichment and Gene Ontology 
Analysis
We performed pathway enrichment analysis, using the 
Reactome Pathways Analysis tool,40 on the final 54 can-
didate genes supported by both CNV and WES data in 
nonsyndromic CHD cases. This resulted in 11 pathways, 
where >5 of our candidate genes were involved in 
those pathways (Table 3). The top 3 pathways based on 
entities ratio (entities found/total entities) from Reac-
tome were axon guidance, signaling by receptor tyro-
Figure 2. Intersection of copy number variant (CNV) and whole-exome 
sequencing (WES) data.  
Numbers of genes involved in the final stages of the workflow depicted in 
Figure 1 are shown. Genes with assigned phenotypes (circles with dashed line) 
were excluded from further analysis. BOTH indicates deleted/duplicated; DEL, 
deletion; DUP, duplication; OMIM, Online Mendelian Inheritance in Man; and 
TOF, Tetralogy of Fallot.
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sine kinases, and cellular responses to external stimuli. 
In addition, ingenuity pathway analysis was also used 
with the only pathway including >5 genes being axon 
guidance signaling. Gene ontology (GO) analysis41 of 
our candidate genes revealed 22 GO terms with par-
ticular enrichment on 4 GO terms; apoptotic process 
involved in luteolysis (GO0061364; FDR corrected P 
value=0.0462), ventricular septum morphogenesis 
(GO0060412; FDR corrected P value=0.00921), ventric-
ular septum development (GO0003281; FDR corrected 
P value=0.0343), and cardiac septum morphogenesis 
(GO0060411; FDR corrected P value=0.036). Both 
pathway and GO analysis identified processes in which 
the genes ABLIM1, ARHGEF12, SLIT2, and SLIT3 are 
involved (Figure 5).
SLIT2 and SLIT3 Variants in CHD
SLIT2 and SLIT3 were the most strongly supported 
genes found both by pathway analysis and GO (Fig-
ure 5). Therefore, we further explored the phenotypic 
associations of these genes within our population.
In the present study, individuals with CNVs including 
SLIT3 were reported with malformation of the heart and 
great vessels (n=1), ventricular septal defect (n=1), atri-
al septal defect (n=3), and TOF (n=1) whereas individu-
als with SLIT2 CNVs were reported with malformation 
of the heart and great vessels (n=1), ventricular septal 
defect (n=2), and double outlet right ventricle (n=1). 
In addition, 20 missense SNVs and 3 splice-site SNVs 
in SLIT3 were found in 24 out of 829 TOF cases (2.9% 
[95% CI, 1.91%–4.35%]) and SLIT2 had 12 missense 
Figure 3. Ohnologs are enriched in congenital heart disease (CHD) cases.  
Graphs show the percentage of genes that are (A) ohnologs, (B) small scale duplications (SSD), and (C) singletons. Statistical significance was tested using 2-tailed 
χ2 test with Yates’s correction, P<0.05 was considered statistically significant. CNV indicates copy number variant.
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SNVs and 2 splice-site SNVs in 14 out of 829 TOF cases 
(1.7% [95% CI, 0.9%–2.9%]). Probands were available 
for 12 SLIT3 variants, and 5 SLIT2 variants which were 
confirmed by Sanger sequencing. Remaining variants 
were confirmed to have good coverage using Integra-
tive Genomics Viewer. Samples from both parents were 
available for 9 probands with SLIT3 variants and were 
analyzed for variant inheritance; 2 of the 9 SLIT3 vari-
ants tested were identified as de novo. Samples from 
both parents were available for 5 probands with SLIT2 
variants and were all either maternally or paternally 
inherited.
DISCUSSION
Here, we performed a large-scale genome-wide meta-
analysis study of nonsyndromic CHD cases and identi-
fied 54 novel candidate genes for CHD. In addition to 
the large size of our data set, we incorporated a novel 
analysis strategy incorporating the evolutionary origin 
of gene duplications. Ohnologs tend not to be observed 
in CNVs in vertebrate genomes.13 Moreover, McLysa-
ght et al14 have also shown that ohnologs are signifi-
cantly overrepresented in pathogenic CNVs associated 
with schizophrenia and neurodevelopmental disorders 
and that they are the possible cause of the deleterious 
effects of these rare pathogenic CNVs. Here, we have 
shown for the first time that genes included in CNVs 
from CHD cases are significantly enriched for ohnologs 
compared with the human genome. Due to this signifi-
cant association between ohnologs and CHD, we incor-
porated ohnolog status in our methodology to identify 
novel genetic loci associated with CHD.
Pathway analysis and GO analysis concordantly iden-
tified the SLIT2 and SLIT3 genes, which have recently 
received increasing attention in heart development.42 
Invertebrates, the Slit family comprises of 3 known 
members (SLIT1-3), which are highly conserved secret-
ed proteins that bind to ROBO (Roundabout receptors). 
SLIT2 and SLIT3 are expressed during mouse embryonic 
development and interact with ROBO1 and ROBO2.43,44 
They both encode proteins that consist of 4 LRR 
domains (leucine-rich repeats) also called D1-D4, 8 EGF 
repeats (epidermal growth factor) and 1 Laminin-G-
like domain.43 Slit3 is expressed early in murine cardio-
genesis in the cardiac crescent at E7.5 and linear heart 
tube at E8.5, later expression being restricted to the 
myocardium of the atria and OFT but not in the cardiac 
cushions or valves.44,45 Slit2 is strongly expressed in the 
pharyngeal region at E8.5-E9.5 and later in the ventric-
ular trabecular myocardium, epicardium, aortic semilu-
nar valves and the mesenchyme surrounding the caval 
veins.44,46 Slit3−/− mutant mice exhibit ventricular septal 
defect, thick atrioventricular valves, and hypoplastic 
posterior aortic semilunar leaflet with Slit2−/− mutant 
mice exhibiting bicuspid aortic valves and immature 
semilunar valves.44 Robo1−/− mutant mice also exhibit 
ventricular septal defect with downregulation of Notch 
signaling, suggesting a potential mechanism for the 
underlying defects.44 In another study, Slit3−/− mice also 
Figure 4. Filtering process using large-scale  
genomic data resources.  
Both graphs are in logarithmic scale and represent the 
consecutive filtering of the genes using the different 
metrics for (A) deleted (DEL) and both copy number 
variant (CNV) genes (B) duplicated (DUP) and both 
CNV genes. There is ≈70% reduction in the number 
of candidate genes when we apply the evolution-
ary duplication metric—ohnolog. Also, none of our 
candidates were present in the list of homozygously 
deleted genes (nonessential) from the Sudmant study 
as well as not present in the list of genes curated from 
the DDD study. LoF indicates loss-of-function; OMIM, 
Online Mendelian Inheritance in Man; pHI, probability 
of haploinsuffieciency; and pLI, probability of loss-of-
function intolerance.
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Table 2. Candidate Genes Supported by both CNV and WES Data of CHD Cases
ENS Gene ID Gene Name Chr
Start 
(hg19)
End 
(hg19)
DEL/DUP/
BOTH
TOF LOF 
Var Count
TOF HIGH 
Impact Var 
Count
TOF MED 
impact Var 
count
Case CNVs 
Overlap: 
FULL
Case CNVs 
Overlap: 
PARTIAL
ENSG00000058668 ATP2B4 1 203595689 203713209 DUP 0 0 13 3 1
ENSG00000064042 LIMCH1 4 41361624 41702061 DUP 6 6 21 4 0
ENSG00000083223 ZCCHC6 9 88902648 88969369 DUP 1 1 8 4 0
ENSG00000092847 AGO1 1 36335409 36395211 DUP 0 0 2 3 0
ENSG00000094916 CBX5 12 54624724 54673886 DUP 0 0 1 2 0
ENSG00000101367 MAPRE1 20 31407699 31438211 DUP 0 0 1 5 0
ENSG00000108387 SEPT4 17 56597611 56618179 DUP 0 0 6 5 1
ENSG00000108389 MTMR4 17 56566898 56595266 DUP 0 0 9 10 0
ENSG00000109332 UBE2D3 4 103715540 103790053 DUP 2 2 0 3 0
ENSG00000109685 WHSC1 4 1873151 1983934 DUP 0 0 12 6 0
ENSG00000112079 STK38 6 36461669 36515247 DUP 0 0 3 5 1
ENSG00000113108 APBB3 5 139937853 139973337 DUP 1 2 8 8 0
ENSG00000122515 ZMIZ2 7 44788180 44809477 DUP 1 1 10 10 0
ENSG00000138641 HERC3 4 89442199 89629693 DUP 0 0 5 14 0
ENSG00000138835 RGS3 9 116207011 116360018 DUP 1 1 19 5 0
ENSG00000140403 DNAJA4 15 78556428 78574538 DUP 0 0 8 9 0
ENSG00000140497 SCAMP2 15 75136071 75165706 DUP 0 0 1 6 0
ENSG00000145147 SLIT2 4 20254883 20622184 DUP 0 0 14 3 0
ENSG00000146463 ZMYM4 1 35734568 35887659 DUP 0 0 12 26 1
ENSG00000179361 ARID3B 15 74833518 74890472 DUP 0 0 6 5 0
ENSG00000185658 BRWD1 21 40556102 40693485 DEL 5 5 16 10 1
ENSG00000151240 DIP2C 10 320130 735683 DEL 1 1 15 4 0
ENSG00000158161 EYA3 1 28296855 28415207 DEL 1 1 2 4 0
ENSG00000106070 GRB10 7 50657760 50861159 DEL 1 2 8 3 0
ENSG00000154127 UBASH3B 11 122526383 122685181 DEL 1 1 5 9 0
ENSG00000092199 HNRNPC 14 21677295 21737653 BOTH 1 1 2 6 0
ENSG00000056586 RC3H2 9 125606835 125667620 BOTH 1 1 8 3 1
ENSG00000184347 SLIT3 5 168088745 168728133 BOTH 2 2 21 3 0
ENSG00000137076 TLN1 9 35696945 35732392 BOTH 4 4 22 9 0
ENSG00000010017 RANBP9 6 13621730 13711796 BOTH 0 0 14 3 0
ENSG00000020577 SAMD4A 14 55033815 55260033 BOTH 0 0 11 8 0
ENSG00000033800 PIAS1 15 68346517 68483096 BOTH 0 0 4 7 1
ENSG00000064726 BTBD1 15 83685174 83736106 BOTH 1 1 7 5 0
ENSG00000083312 TNPO1 5 72112139 72212560 BOTH 0 0 4 5 0
ENSG00000091009 RBM27 5 145583113 145718814 BOTH 0 0 7 4 0
ENSG00000099204 ABLIM1 10 116190872 116444762 BOTH 3 3 14 12 0
ENSG00000100320 RBFOX2 22 36134783 36424473 BOTH 0 0 5 2 0
ENSG00000100330 MTMR3 22 30279144 30426855 BOTH 0 0 11 4 0
ENSG00000100592 DAAM1 14 59655364 59838123 BOTH 0 0 9 14 0
ENSG00000113649 TCERG1 5 145826874 145891524 BOTH 0 0 6 9 0
ENSG00000116191 RALGPS2 1 178694300 178889238 BOTH 0 0 1 2 0
ENSG00000120899 PTK2B 8 27168999 27316903 BOTH 0 0 8 4 0
ENSG00000127022 CANX 5 179105629 179157926 BOTH 0 0 10 2 0
ENSG00000135074 ADAM19 5 156822542 157002783 BOTH 2 2 10 7 1
(Continued )
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exhibit congenital diaphragmatic hernia.47 Congenital 
heart defects ranging from bicuspid aortic valves to sep-
tal, and outflow tract defects are, therefore, observed 
in variety of animal models in which genes involved in 
the SLIT/ROBO pathway have been inactivated.
We identified SLIT2 and SLIT3 heterozygous SNVs in 
2.9% and 1.7% nonsyndromic TOF patients, respec-
tively. All SNVs were novel or rare (either absent from 
ExAC or with frequency of <0.01) and predicted with in 
silico tools to be pathogenic. The majority of the SNVs 
in both genes were missense, although a few splice-
site SNVs were also found. Their functional relevance 
will be of interest in future studies. Both genes were 
also present in CNVs in patients with CHD with varying 
phenotypes, including septal defects and malformation 
of the great arteries. This is the first study to find an 
association of SLIT2 and SLIT3 with predisposition to 
human CHD, although, of note, a recent study iden-
tified ROBO1 loss-of-function SNVs in cases with TOF 
and septal defects.48
Limitations
This study has certain limitations. The databases and 
publications included in this analysis incorporated dif-
ferent CNV detection platforms and analysis algo-
rithms.49 Irrespective of the method used in the studies 
identifying pathogenic CNVs, we only included stud-
ies that used the same genotyping method between 
cases and controls and confirmed their CNV detection 
by an additional methodology like quantitative poly-
merase chain reaction, which to a degree addresses 
this limitation. Another potential limitation is the fact 
that during our filtering strategy, we might have missed 
some important genes crucial for cardiac development. 
Though we accept that all important genes will not 
have been captured, we detected 54 strong candidate 
Table 3. Top Pathways Overrepresented in Our 54 Candidate Genes
Pathway Tool Pathway Name *Entities Found *Entities Total Entities Ratio (%)
Reactome Axon guidance 8 583 1.372212693
Ingenuity pathway analysis Axon guidance signaling pathway 7 501 1.397206
Reactome Signaling by receptor tyrosine kinases 5 521 0.959692898
Reactome Cellular responses to external stimuli 5 621 0.805152979
Reactome Signaling by interleukins 5 641 0.780031201
Reactome Developmental biology 8 1177 0.679694138
Reactome Adaptive immune system 6 998 0.601202405
Reactome Cytokine signaling in immune system 6 1056 0.568181818
Reactome Signal transduction 15 3202 0.468457214
Reactome Post-translational protein modification 7 1594 0.439146801
Reactome Immune system 11 2662 0.41322314
Reactome Metabolism of proteins 9 2354 0.382327952
*Number.
ENSG00000137573 SULF1 8 70378859 70573150 BOTH 1 1 10 3 0
ENSG00000137962 ARHGAP29 1 94614544 94740624 BOTH 0 0 12 3 0
ENSG00000138107 ACTR1A 10 104238986 104262482 BOTH 0 0 2 2 1
ENSG00000155506 LARP1 5 154092462 154197167 BOTH 2 2 13 6 0
ENSG00000166747 AP1G1 16 71762913 71843104 BOTH 0 1 4 4 1
ENSG00000166888 STAT6 12 57489191 57525922 BOTH 0 0 7 5 0
ENSG00000180340 FZD2 17 42634925 42636907 BOTH 0 0 8 8 0
ENSG00000180776 ZDHHC20 13 21950263 22033509 BOTH 1 1 2 6 0
ENSG00000196914 ARHGEF12 11 120207787 120360645 BOTH 0 0 14 12 0
ENSG00000213079 SCAF8 6 155054459 155155192 BOTH 0 0 13 14 0
Fifty-four protein-coding candidate genes supported by CNV and WES data in nonsyndromic CHD cases. All genes in the list are strict ohnologs. Data presented 
includes the Ensembl ID and the nature of the chromosomal imbalance for which the gene is either deleted (DEL), duplicated (DUP), or deleted/duplicated (BOTH). 
Chr indicates chromosome; ENS, ensemble; LoF, loss-of-function; MED, medium impact; TOF, tetralogy of Fallot; and Var, variants.
Table 2. Continued
ENS Gene ID Gene Name Chr
Start 
(hg19)
End 
(hg19)
DEL/DUP/
BOTH
TOF LOF 
Var Count
TOF HIGH 
Impact Var 
Count
TOF MED 
impact Var 
count
Case CNVs 
Overlap: 
FULL
Case CNVs 
Overlap: 
PARTIAL
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genes supported by multiple lines of evidence as having 
a causative role in nonsyndromic CHD. Further research 
in much larger numbers of comprehensively genetically 
characterized CHD cases is warranted to establish the 
magnitude of the contribution of these genes, and to 
discover novel loci.
In conclusion, we show that ohnologs are overrep-
resented in CHD cases and that incorporation of the 
evolutionary origins of genes is useful in refining can-
didate genes emerging from large-scale genetic evalu-
ations of CHD. We also observe that CNVs and SNVs 
in SLIT2 and SLIT3 are associated with CHD involving 
TOF, septal defects, and outflow tract defects, support-
ing the importance of the SLIT-ROBO signaling pathway 
in heart development.
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